NCT04934696View on ClinicalTrials.gov

A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

January 25, 2022

Study Completion Date

January 25, 2022

Conditions
Healthy Participants
Interventions
DRUG

BMS-986166

Specified dose on specified days

DRUG

Oral contraceptive

Specified dose on specified days

Trial Locations (1)

90630

West Coast Clinical Trials Global, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04934696 - A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential | Biotech Hunter | Biotech Hunter